TELIX PHARMACEUTICALS LIMITED
TELIX PHARMACEUTICALS LIMITED is a Public Limited Company registered in Australia under 85616620369, and its current status with Australian Securities and Investments Commission (ASIC) is active. The company was incorporated on 3 January 2017 and lists its registered address as Australia. 5 shareholders are on record for TELIX PHARMACEUTICALS LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Australian Securities and Investments Commission (ASIC) and was last updated on 24 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of TELIX PHARMACEUTICALS LIMITED
Five shareholders are currently on record for TELIX PHARMACEUTICALS LIMITED, held on the share register, filed under section 168 of the Corporations Act 2001. The largest of these is iShares Trust-iShares MSCI EAFE Small-Cap ETF, holding 6.5% — the largest recorded stake — followed by VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd. at 4.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 21 shareholders in total, though only the top 5 by holding are shown in this view.
Officers
5
Directors and officers of TELIX PHARMACEUTICALS LIMITED
The Chief Information Officer of TELIX PHARMACEUTICALS LIMITED on record is Craig Ulrick; 5 officers are shown here, filed with Australian Securities and Investments Commission (ASIC). Management authority at TELIX PHARMACEUTICALS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 13 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Group Structure
Group structure of TELIX PHARMACEUTICALS LIMITED
TELIX PHARMACEUTICALS LIMITED has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 4 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Telix Pharmaceuticals (us) Inc. (United States)
- TELIX PHARMACEUTICALS HOLDINGS PTY LTD (Australia)
- Telix ARTMS Inc (Canada)
- Telix Pharmaceuticals (Belgium) (Belgium)
Data availability
Those 4 subsidiaries span Australia, United States, Canada, Belgium jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 4 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns TELIX PHARMACEUTICALS LIMITED?
Five shareholders are currently on record for TELIX PHARMACEUTICALS LIMITED, held on the share register, filed under section 168 of the Corporations Act 2001. The largest of these is iShares Trust-iShares MSCI EAFE Small-Cap ETF, holding 6.5% — the largest recorded stake — followed by VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd. at 4.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is TELIX PHARMACEUTICALS LIMITED's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for TELIX PHARMACEUTICALS LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does TELIX PHARMACEUTICALS LIMITED have on record?
5 shareholders are shown on record for TELIX PHARMACEUTICALS LIMITED. The register reports 21 in total; only the top 5 by holding are shown here.
What is TELIX PHARMACEUTICALS LIMITED's company registration number?
TELIX PHARMACEUTICALS LIMITED's registration number is 85616620369, filed with Australian Securities and Investments Commission (ASIC) in Australia. Its current status on the register is active.
Is TELIX PHARMACEUTICALS LIMITED still an active company?
TELIX PHARMACEUTICALS LIMITED's status on Australian Securities and Investments Commission (ASIC) is listed as active.
When was TELIX PHARMACEUTICALS LIMITED incorporated?
TELIX PHARMACEUTICALS LIMITED was incorporated on 3 January 2017, according to Australian Securities and Investments Commission (ASIC).
What is TELIX PHARMACEUTICALS LIMITED's registered address?
The registered address on file for TELIX PHARMACEUTICALS LIMITED is Australia.
What legal structure is TELIX PHARMACEUTICALS LIMITED registered as?
TELIX PHARMACEUTICALS LIMITED is registered as a Public Limited Company in Australia.
Who are the officers/directors of TELIX PHARMACEUTICALS LIMITED?
The Chief Information Officer of TELIX PHARMACEUTICALS LIMITED on record is Craig Ulrick; 5 officers are shown here, filed with Australian Securities and Investments Commission (ASIC). Management authority at TELIX PHARMACEUTICALS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does TELIX PHARMACEUTICALS LIMITED have a parent company or subsidiaries?
TELIX PHARMACEUTICALS LIMITED has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 4 jurisdictions. Those 4 subsidiaries span Australia, United States, Canada, Belgium jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 4 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to TELIX PHARMACEUTICALS LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Australian Securities and Investments Commission (ASIC). Zavia's monitoring API can track changes to TELIX PHARMACEUTICALS LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access TELIX PHARMACEUTICALS LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Australia, so records like TELIX PHARMACEUTICALS LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Australian Securities and Investments Commission (ASIC) and was last synced on 24 September 2026.